Shopping Cart
- Remove All
- Your shopping cart is currently empty
MK-0626 is an orally available dipeptidyl peptidase IV (DPP-4) inhibitor that attenuates hepatic steatosis and accumulation by enhancing AMPK activity.MK-0626 attenuates TAC-induced diabetic pancreatic islet injury by restoring the expression of GLP-1R.MK-0626 is able to increase circulating endothelial progenitor cell numbers and endothelial-type nitric oxide synthase expression by promoting neoangiogenesis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $3,970 | In Stock | |
50 mg | $5,550 | In Stock | |
100 mg | $7,490 | In Stock |
Description | MK-0626 is an orally available dipeptidyl peptidase IV (DPP-4) inhibitor that attenuates hepatic steatosis and accumulation by enhancing AMPK activity.MK-0626 attenuates TAC-induced diabetic pancreatic islet injury by restoring the expression of GLP-1R.MK-0626 is able to increase circulating endothelial progenitor cell numbers and endothelial-type nitric oxide synthase expression by promoting neoangiogenesis. |
In vivo | Methods: ob/ob mice were treated with MK-0626 (1.5 and 3 mg/kg, oral), blood samples were collected, and total hepatectomy was performed. Results: MK-0626 treatment increased the mRNA expression of peroxisome proliferator-activated receptor α/microsomal triglyceride transfer protein, but decreased the mRNA expression of sterol regulatory element binding transcription factor-1c/fatty acid synthase/stearoyl-CoA desaturase-1. [1] |
Alias | MK0626 |
Molecular Weight | 442.46 |
Formula | C22H24F2N6O2 |
Cas No. | 690257-74-0 |
Smiles | [C@H]([C@@H](C(=O)N1CC(F)(F)CC1)N)(C(N(C)C)=O)C2=CC=C(C=C2)C3=CN4C(C=C3)=NC=N4 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.